102 related articles for article (PubMed ID: 702944)
41. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Gillies LK; Lu M; Wang H; Lee RM
Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
[TBL] [Abstract][Full Text] [Related]
42. [Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine excretion rate in stroke-prone, spontaneously hypertensive rats].
Minami M; Togashi H; Sano M; Yoshioka M; Saito I; Morii K; Tochihara M; Hirogami M; Nomura A; Saito H
Hokkaido Igaku Zasshi; 1985 Jul; 60(4):536-43. PubMed ID: 4054822
[TBL] [Abstract][Full Text] [Related]
43. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
Ishii H; Itoh K; Nose T
Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensive effect of trichlormethiazide in spontaneously hypertensive rats.
Ueda M; Matsuda S; Tonda K; Matsunaga K
Jpn J Pharmacol; 1978 Aug; 28(4):617-26. PubMed ID: 732042
[TBL] [Abstract][Full Text] [Related]
45. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.
Tsoporis J; Leenen FH
Hypertension; 1988 Apr; 11(4):376-86. PubMed ID: 2895737
[TBL] [Abstract][Full Text] [Related]
46. Long-term study of oxdralazine in hypertensive patients.
Salvadeo A; Villa G; Segagni S; Criscuolo D
Arzneimittelforschung; 1979; 29(11):1753-5. PubMed ID: 396926
[TBL] [Abstract][Full Text] [Related]
47. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
Malherbe E; Le Hegarat M; Clostre F; Braquet P
Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
[TBL] [Abstract][Full Text] [Related]
48. [Kidney function in spontaneously hypertensive rats under minoxidil treatment].
Hagemann I; Su LM; Strangfeld D; Pietsch R; Kruse I; Schürer M; Siewert H; Moritz V; Massow S; Scholze J
Biomed Biochim Acta; 1987; 46(6):505-15. PubMed ID: 3675567
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.
Semeraro C; Dorigotti L; Banfi S; Carpi C
J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827
[TBL] [Abstract][Full Text] [Related]
50. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
Smits JF; Struyker-Boudier HA
J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
[TBL] [Abstract][Full Text] [Related]
51. Lipophilic and hydrophilic esters of 4-acetyl-2-(2-hydroxyethyl)-5,6-bis(4-chlorophenyl)-2H-pyridazin-3-one as antihypertensive agents.
Fogt SW; Scozzie JA; Heilman RD; Powers LJ
J Med Chem; 1980 Dec; 23(12):1445-8. PubMed ID: 7452699
[TBL] [Abstract][Full Text] [Related]
52. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats.
Ruskoaho H; Leppäluoto J
Circ Res; 1988 Feb; 62(2):384-94. PubMed ID: 2962785
[TBL] [Abstract][Full Text] [Related]
53. Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats.
Ahmad FU; Sattar MA; Rathore HA; Tan YC; Akhtar S; Jin OH; Pei YP; Abdullah NA; Johns EJ
Ren Fail; 2014 May; 36(4):598-605. PubMed ID: 24502512
[TBL] [Abstract][Full Text] [Related]
54. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
55. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
[TBL] [Abstract][Full Text] [Related]
56. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
[TBL] [Abstract][Full Text] [Related]
57. Effects of the antihypertensive drugs alpha-methyldopa and hydralazine on the performance of spontaneously hypertensive rats in the elevated plus-maze.
Rosa WC; Oliveira GM; Nakamura-Palacios EM
Braz J Med Biol Res; 1994 Jan; 27(1):55-9. PubMed ID: 8173530
[TBL] [Abstract][Full Text] [Related]
58. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
[TBL] [Abstract][Full Text] [Related]
59. Evidence of an altered in vivo vascular cell turnover in spontaneously hypertensive rats and its modulation by long-term antihypertensive treatment.
Thorin-Trescases N; deBlois D; Hamet P
J Cardiovasc Pharmacol; 2001 Nov; 38(5):764-74. PubMed ID: 11602823
[TBL] [Abstract][Full Text] [Related]
60. Hydroxyhydroquinone interferes with the chlorogenic acid-induced restoration of endothelial function in spontaneously hypertensive rats.
Suzuki A; Fujii A; Jokura H; Tokimitsu I; Hase T; Saito I
Am J Hypertens; 2008 Jan; 21(1):23-7. PubMed ID: 18091740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
